Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
Resource Type
Article
Authors
Danese, Silvio ; Vermeire, Séverine ; Zhou, Wen ; Pangan, Aileen L ; Siffledeen, Jesse ; Greenbloom, Susan ; Hébuterne, Xavier ; D'Haens, Geert ; Nakase, Hiroshi ; Panés, Julian ; Higgins, Peter D R ; Juillerat, Pascal ; Lindsay, James O ; Loftus, Edward V, Jr ; Sandborn, William J ; Reinisch, Walter ; Chen, Min-Hu ; Sanchez Gonzalez, Yuri ; Huang, Bidan ; Xie, Wangang ; Liu, John ; Weinreich, Michael A ; Panaccione, Remo
Source
In The Lancet 4-10 June 2022 399(10341):2113-2128
Subject
Primary Research Articles
Language
ISSN
0140-6736